Lazard Asset Management
RARE icon

Lazard Asset Management’s Ultragenyx Pharmaceutical RARE Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$21K Sell
588
-33,455
-98% -$1.19M ﹤0.01% 2120
2025
Q1
$1.23M Buy
34,043
+34,029
+243,064% +$1.23M ﹤0.01% 1143
2024
Q4
$0 Sell
14
-18,700
-100% ﹤0.01% 2490
2024
Q3
$1.04M Buy
18,714
+18,677
+50,478% +$1.04M ﹤0.01% 1062
2024
Q2
$0 Sell
37
-4,123
-99% ﹤0.01% 2392
2024
Q1
$193K Buy
4,160
+2,433
+141% +$113K ﹤0.01% 1307
2023
Q4
$82K Sell
1,727
-1,763
-51% -$83.7K ﹤0.01% 1741
2023
Q3
$123K Buy
3,490
+1,900
+119% +$67K ﹤0.01% 1553
2023
Q2
$73K Sell
1,590
-1,320
-45% -$60.6K ﹤0.01% 1698
2023
Q1
$115K Buy
2,910
+332
+13% +$13.1K ﹤0.01% 1480
2022
Q4
$118K Buy
2,578
+279
+12% +$12.8K ﹤0.01% 1465
2022
Q3
$95K Buy
2,299
+1,366
+146% +$56.4K ﹤0.01% 1496
2022
Q2
$54K Buy
933
+37
+4% +$2.14K ﹤0.01% 1777
2022
Q1
$64K Buy
896
+240
+37% +$17.1K ﹤0.01% 1622
2021
Q4
$54K Buy
656
+117
+22% +$9.63K ﹤0.01% 1705
2021
Q3
$48K Sell
539
-1,000
-65% -$89.1K ﹤0.01% 1704
2021
Q2
$145K Buy
1,539
+796
+107% +$75K ﹤0.01% 1264
2021
Q1
$84K Hold
743
﹤0.01% 1250
2020
Q4
$102K Buy
743
+16
+2% +$2.2K ﹤0.01% 1180
2020
Q3
$59K Sell
727
-354
-33% -$28.7K ﹤0.01% 1135
2020
Q2
$84K Sell
1,081
-754
-41% -$58.6K ﹤0.01% 1065
2020
Q1
$81K Buy
1,835
+1,401
+323% +$61.8K ﹤0.01% 1044
2019
Q4
$18K Buy
434
+179
+70% +$7.42K ﹤0.01% 1260
2019
Q3
$10K Buy
+255
New +$10K ﹤0.01% 1306
2017
Q2
Sell
-24,225
Closed -$1.64M 1041
2017
Q1
$1.64M Sell
24,225
-525
-2% -$35.6K ﹤0.01% 673
2016
Q4
$1.74M Hold
24,750
﹤0.01% 637
2016
Q3
$1.76M Hold
24,750
﹤0.01% 633
2016
Q2
$1.21M Hold
24,750
﹤0.01% 670
2016
Q1
$1.57M Sell
24,750
-840
-3% -$53.1K ﹤0.01% 637
2015
Q4
$2.87M Sell
25,590
-2,060
-7% -$231K 0.01% 603
2015
Q3
$2.66M Buy
+27,650
New +$2.66M 0.01% 568